Get started
CLARITY PHARMACEUTICALS LTDCLARITY PHARMACEUTICALS LTDCLARITY PHARMACEUTICALS LTD

CLARITY PHARMACEUTICALS LTD

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

CU6 chart


Full chart

CU6 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪2.31 B‬ AUD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.15 AUD
Net income (FY)
‪−42.32 M‬ AUD
Revenue (FY)
0.00 AUD
Shares float
‪208.74 M‬
Beta (1Y)
1.51

About CLARITY PHARMACEUTICALS LTD


Sector
Health Technology
Industry
Medical Specialties
CEO
Michelle Parker
Website
claritypharmaceuticals.com
Headquarters
Eveleigh
Founded
2010
ISIN
AU0000165375
FIGI
BBG011WVJ0L8
Clarity Pharmaceuticals Ltd. is a clinical stage radiopharmaceutical company. It engages in research and development and clinical stage evaluation of its portfolio of novel radiopharmaceuticals products. The company was founded by Matthew Harris on April 8, 2010 and is headquartered in Eveleigh, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

CU6 news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of CU6 is 7.46 AUD — it has decreased by −0.27% in the past 24 hours. Watch CLARITY PHARMACEUTICALS LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange CLARITY PHARMACEUTICALS LTD stocks are traded under the ticker CU6.
CU6 stock has risen by 5.82% compared to the previous week, the month change is a 6.42% rise, over the last year CLARITY PHARMACEUTICALS LTD has showed a 568.14% increase.
We've gathered analysts' opinions on CLARITY PHARMACEUTICALS LTD future price: according to them, CU6 price has a max estimate of 10.00 AUD and a min estimate of 8.20 AUD. Watch CU6 chart and read a more detailed CLARITY PHARMACEUTICALS LTD stock forecast: see what analysts think of CLARITY PHARMACEUTICALS LTD and suggest that you do with its stocks.
CU6 reached its all-time high on Sep 23, 2024 with the price of 8.98 AUD, and its all-time low was 0.36 AUD and was reached on Jun 23, 2022. View more price dynamics on CU6 chart.
See other stocks reaching their highest and lowest prices.
CU6 stock is 4.11% volatile and has beta coefficient of 1.51. Track CLARITY PHARMACEUTICALS LTD stock price on the chart and check out the list of the most volatile stocks — is CLARITY PHARMACEUTICALS LTD there?
Today CLARITY PHARMACEUTICALS LTD has the market capitalization of ‪2.40 B‬, it has increased by 3.00% over the last week.
Yes, you can track CLARITY PHARMACEUTICALS LTD financials in yearly and quarterly reports right on TradingView.
CLARITY PHARMACEUTICALS LTD is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
CU6 earnings for the last half-year are −0.06 AUD per share, whereas the estimation was −0.05 AUD, resulting in a −14.48% surprise. The estimated earnings for the next half-year are −0.07 AUD per share. See more details about CLARITY PHARMACEUTICALS LTD earnings.
CLARITY PHARMACEUTICALS LTD revenue for the last half-year amounts to ‪6.09 M‬ AUD, despite the estimated figure of ‪4.93 M‬ AUD. In the next half-year revenue is expected to reach ‪5.92 M‬ AUD.
CU6 net income for the last half-year is ‪−25.12 M‬ AUD, while the previous report showed ‪−17.20 M‬ AUD of net income which accounts for −46.03% change. Track more CLARITY PHARMACEUTICALS LTD financial stats to get the full picture.
No, CU6 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CU6 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CLARITY PHARMACEUTICALS LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CLARITY PHARMACEUTICALS LTD technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CLARITY PHARMACEUTICALS LTD stock shows the buy signal. See more of CLARITY PHARMACEUTICALS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.